Journal of Jilin University Medicine Edition ›› 2016, Vol. 42 ›› Issue (01): 191-194.doi: 10.13481/j.1671-587x.20160139
Received:2015-09-01
Published:2016-01-26
CLC Number:
| [1] 刘虹霞.老年糖尿病药物的治疗进展[J].糖尿病新世界,2014(18):12-13.[2] Suggested citation:American Diabetes Association.Older adults.Sec.10.In Standards of Medical Care in Diabetesd 2015[J].Diabetes Care, 2015,38(Suppl1):S67-S69.[3] Selvin E,Parrinello CM,Sacks DB,et al.Trends in prevalence and control of diabetes in the United States,1988-1994 and 1999-2010[J].Ann Int Med, 2014,160(8):517-525.[4] Migdal A,Yarandi SS,Smiley D,et al.Update on diabetes in the elderly and in nursing home residents[J].J Am Med Dir Assoc,2011,12(9):627-632.e2.[5] Currie CJ,Peters JR,Tynan A,et al.Survival as a function of HbA1c in people with type 2 diabetes:a retrospective cohort study[J].Lancet, 2010,375(9713): 481-489.[6] Huang ES,Liu JY,Moffet HH,et al.Glycemic control,complications,and death in older diabetic patients:the diabetes and aging study[J].Diabetes Care, 2011,34(6):1329-1336.[7] Sanon VP,Sanon S,Kanakia R,et al.Hypoglycemia from a cardiologist's perspective[J].Clin Cardiol, 2014,37(8):499-504.[8] Kimbro LB,Mangione CM,Steers WN,et al.Depression and all-cause mortality in persons with diabetes mellitus:are older adults at higher risk? Results from the Translating Research Into Action for Diabetes Study[J].J Am Geriatr Soc, 2014,62(6):1017-1022.[9] 刘铜华.老年糖尿病的临床特点与合理用药[A].中国药学会学术年会暨第八届中国药师周报告集[C].2008:57-59.[10] 刘铜华.老年糖尿病的临床特点与中西药联合应用[J].中华中医药杂志,2009,24(8):1038-1041.[11] 中国老年学会老年医学会老年内分泌代谢专业委员会,老年糖尿病诊治措施专家共识编写组.老年糖尿病诊疗措施专家共识(2013年版)[J].中华内科杂志,2014,53(3):243-251.[12] Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency[J]. Diabetes Care, 2011,34(6):1431-1437.[13] Sinclair A,Morley JE,Rodriguez-Mañas L,et al.Diabetes mellitus in older people:position statement on behalf of the International Association of Gerontology and Geriatrics(IAGG),the European Diabetes Working Party for Older People (EDWPOP),and the international task force of experts in diabetes[J]. J Am Med Dir Assoc, 2012,13(6):497-502.[14] Kirkman MS,Briscoe VJ,Clark N,et al.Diabetes in older adults: a consensus report[J].J Am Geriatr Soc,2012,60(12):2342-2356.[15] Gooben K,Gräber S.Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus:systematic review and meta-analysis[J].Diabetes Obes Metab, 2012,14(12):1061-1072.[16] Thearle M,Brillantes AM.Unique characteristics of the geriatric diabetic population and the role for therapeutic strategies that enhance glucagon-like peptide-1 activity[J].Curr Opin Clin Nutr Metab Care, 2005,8(1):9-16.[17] American Geriatrics Society 2012 Beers Griteria Update Expert Panel. American Geriatrics Society update beers criteria for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc,2012,60(4):616-631.[18] Vasilakou D, Karagiannis T, Athanasiadou E, et al. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes:a systematic review and metaanalysis[J]. Ann Intern Med, 2013,159(4):262-274.[19] Monami M, Nardini C, Mannucci E. Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials[J]. Diabetes Obes Metab, 2014,16(5):457-466.[20] Phung OJ, Sobieraj DM, Engel SS, et al. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis[J]. Diabetes Obes Metab, 2014,16(5):410-417.[21] Diamant M, Nauck MA, Shaginian R, Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes[J]. Diabetes Care, 2014, 37(10):2763-2773.[22] Eng C, Kramer CK, Zinman B, et al. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis[J]. Lancet, 2014,384(9961):2228-2234.[23] Gough SC,Harris S,Woo V,et al.Insulin degludec:overview of a novel ultra long-acting basal insulin[J].Diabetes Obes Metab, 2013,15(4):301-309.[24] Ismail-Beigi F,Moghissi E,Tiktin M,et al.Individualizing glycemic targets in type 2 diabetes mellitus:implications of recent clinical trials[J]. Ann Intern Med, 2011,154(8):554-559.[25] Buse JB,Wolffenbuttel BH,Herman WH,et al.The Durability of Basal versus Lispro mix 75/25 insulin Efficacy(DURABLE)trial:comparing the durability of lispro mix 75/25 and glargine[J].Diabetes Care,2011,34(2):249-255.[26] Eli Lilly and Company.Comparison of the efficacy and safety of two insulin intensification strategies[EB/OL].http://clinicaltrials.gov/show/NCT01175824,2014-06.[27] Rosenstock J,Ahmann AJ,Colon G,et al.Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents:prandial premixed(insulin lispro protamine suspension/lispro)versus basal/ bolus(glargine/lispro)therapy[J].Diabetes Care,2008,31(1):20-25.[28] 中华医学会内分泌学分会.预混胰岛素临床应用共识[J].药品评价,2013,10(11):33-38.[29] 周 迪,鹿 斌.中国血糖监测临床应用指南(2011年版)解读[J]. 上海医药,2012,33(4):6-9.[30] 中华医学会糖尿病学分会.中国血糖监测临床应用指南(2011年版)[J].中华医学杂志,2011,91(10):656-664.[31] Morley JE,Sinclair A.Individualising treatment for older people with diabetes[J].Lancet,2013,382(9890):378-380.[32] Arauz-Pacheco C,Parrott MA,Raskin P,et al.Hypertension management in adults with diabetes[J].Diabetes Care,2004,27(Suppl1):S65-S67.[33] Schall P,Wehling M.Treatment of arterial hypertension in the very elderly:a meta-analysis of clinical trials[J].Arzneimittelforschung,2011,61(4):221-228.[34] 戴 靖,郭立新.2013国际糖尿病联盟老年2型糖尿病管理指南解读[J].中国医学前沿杂志:电子版,2014,6(2):98-102.[35] Cholesterol Treatment Trialists'(CTT)Collaboration,Baigent C,Blackwell L,et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170000 participants in 26 randomised trials[J].Lancet,2010,376(9753):1670-1681.[36] Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report[J]. Diabetes Care, 2012, 35(12): 2650-2664.[37] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.[38] International Diabetes Federation. IDF Diabetes Atlas[S]. 6th ed. Belgium:Brussels, 2013. |
| [1] | PAN Hong, WANG Yufeng, HUANG Haipeng, ZHANG Liying, ZHONG Zhen, MA Shiqi, DONG Li, WANG Hongfeng. Influence of Adjust Zang Dredge Meridian electroacupuncture in expression of GRP78 in sciatic nerve cells of rats with diabetic peripheral neuropathy and its neuroprotective effect [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1124-1130. |
| [2] | QI Lu, BAI Wei, YU Weiying, LI Yuanyuan, HUA Wanqing, KOU Changgui. Randomized controlled trials for curative effect of saxagliptin combined with insulin in treatment of patients with type 2 diabetes mellitus: Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1235-1242. |
| [3] | QI Bingxue, SUN Yadong. A prospective study on primary prevention of major vascular lesions of type 2 diabetes mellitus patients in Han population in Northeast China [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1243-1248. |
| [4] | DONG Xuemei, WANG Lijuan, SHEN Hong, ZHAO Yan, ZHANG Xiujuan, QIAO Yue, CAI Hanqing. Application of insulin dose adjustment in blood glucose control in patients with type 2 diabetes treated by insulin pump [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1280-1285. |
| [5] | CHEN Yingbo, SONG Dan, WU Jin, JING Zuolei, LIU Liping, JIANG Rujiao, SUN Jie, WU Yingjie. Improvement effects of Dendrobium candidum on insulin resistance in MKR mice and MIN6 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 709-717. |
| [6] | HUANG Kaiwen, LI Arong, DENG Zhijun, LIU Ruoxuan, LI Changqing, ZHONG Shishun, GUO Jiewen, ZHANG Jie, CHEN Bin. Improvement effect of saponin of litchi seed on oxidative stress of pancreas tissue in impaired glucose regulation rats and its mechanism [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 746-752. |
| [7] | . Research progress in effects of DNA and histone epigenetic modifications in pathogenesis of type 2 diabetes [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 853-858. |
| [8] | WANG Haibin, DONG Zhijun, GUO Litao, SHI Jing, DONG Weili. Protective effect of Purendan Superfine Powder on retinopathy of rats with diabetes mellitus induced by streptozotocin and its influence in NF-κB signaling pathway [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 759-763. |
| [9] | SUN Zhumei, LIANG Weishi, KANG Jiali, MENG Xubing, WANG Jianxing, HAN Shuying. Dynamic pathological characteristics of kidney in db/db mice with type 2 diabetes mellitus [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 499-503. |
| [10] | . Research progress in expression of microRNA in differentiation process of stem cells into insulin producing cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 675-678. |
| [11] | PANG Chunyan, WANG Hui, WANG Zhihua, FENG Xiuyuan, WANG Yongfu. Effect of co-expression of IL-10 and sleeping beauty transposon on balance of Th17/Treg cells in splenocytes of NOD mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 205-210. |
| [12] | LIU Xiaojie, MEI Tao, MA Hongyan, YE Shandong. Analysis of influencing factors of carotid atherosclerosis plaque formation and stability in simple type 2 diabetic patients [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 350-355. |
| [13] | LI Chunhua, GUO Xin, DOU Jing, DING Mingxuan, YAO Yan, ZHANG Yanqiu. Survey analysis on cognitive dysfunction in patients with type 2 diabetes mellitus and its influecing factors [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 431-437. |
| [14] | WANG Jianxing, JIANG Yan, WANG Yan, WU Lei, MU Yu, HAN Shuying. Influence of extract from fermented buckwheat flower and leaf in kidney injury in type 2 diabetic db/db mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 95-100. |
| [15] | LI Cai, WEI Jie, ZHEN Yongzhan, DAI Minghe, HU Gang, GUO Lixin, LIN Yajun. Improvement effect of rhein lysinate on insulin resistance of KK/HlJ diabetic mice and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1074-1079. |
|
||